NCT07198958View on ClinicalTrials.gov

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2045

Study Completion Date

September 30, 2045

Conditions

CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Cancer (Solid Tumors)Cancer (With or Without Metastasis)

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER